On April 12, 2023 Biomunex Pharmaceuticals, a French biopharmaceutical company focused on the development of immunotherapies based on the discovery and development of bi- and multi-specific antibodies for the treatment of cancer, reported that it will participate in and present new scientific data at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) annual meeting, which will take place from April 14th to April 19th, 2023 at the Orange County Convention Center, Orlando, Florida, USA (Press release, BIOMUNEX Pharmaceuticals, APR 12, 2023, View Source [SID1234630024]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Information about the presentation:
Title: MAIT engagers: An efficacious novel modality in the field of T-cell engagers for the treatment of solid tumors
Session Category: Immunology
Session Title: Therapeutic Antibodies 3
Session Date and Time: Monday Apr 17, 2023 1:30 PM – 5:00 PM
Location: Poster Section 24
Poster Board Number: 1
Published Abstract Number: 2954